Dynavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. AWK

Go back to Dynavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Financial Guidance

Dynavax (DVAX) Tops Q4 EPS by 11c

February 28, 2022 4:05 PM EST

Dynavax (NASDAQ: DVAX) reported Q4 EPS of $0.80, $0.11 better than the analyst estimate of $0.69. Revenue for the quarter came in at $195.1 million versus the consensus estimate of $208.87 million.

GUIDANCE:

2022 Financial GuidanceIn 2022, Dynavax anticipates:

Full year CpG 1018 adjuvant net product revenues... More